Papillomaviruses in human cancers

Proceedings of the Association of American Physicians

Volumn 111, Issue 6, 1999, Pages 581-587

  Zur Hausen, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AP I heterodimerization; Cervical cancer; HPV genotypes; HPV vaccination; Tumor necrosis factor ; Viral oncogenes

Indexed keywords

VIRUS VACCINE;

BASAL CELL CARCINOMA; CARCINOGENICITY; DISEASE COURSE; ESOPHAGUS CANCER; GENE EXPRESSION; KERATINOCYTE; OROPHARYNX CANCER; PAPILLOMA VIRUS; PENIS CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS INFECTION; VIRUS ONCOGENE; VULVA CANCER; WART VIRUS;

EID: 0032743399     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99723.x     Document Type: Review

References (41)

1. 1 Zur Hausen H. Papillomavirus infections—a major cause of human cancers. Biochem. Biophys. Acta 1288: F55 F78, 1996.
2. 2 De Villiers E.‐M. Human pathogenic papillomavirus types: An update. Curr. Top. Microbiol. Immunol. 186: 1 12, 1994.
3. 3 McDougall J.K. Immortalization and transformation of human cells by human papillomavirus. Curr. Top. Microbiol. Immunol. 186: 101 119, 1994.
4. 4 Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18, E6 proteins with p53. Science 248: 76 79, 1990.
5. 5 Scheffner M., Werness B.A., Huibregtse J.M., et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129 1136, 1990.
6. 6 Huibregtse J.M., Scheffner M., Beaudenon S., Howley P.M. A family of proteins structurally and functionally related to the E6‐AP ubiquitin‐protein ligase. Proc. Natl. Acad. Sci. U.S.A. 92: 2563 2567, 1995.
7. 7 Howley P.M. and Münger K. Human papillomaviruses and cancer. In: Parsonnet J. and Horning S. (eds). Microbes and Malignancy. Oxford: Oxford University Press (in press).
8. 8 Reznikoff C.A., Yeager T.R., Belair C.D., et al. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16, E6, but not in E7, transformed human uroepithelial cells. Cancer Res. 56: 2886 2890, 1996.
9. 9 Tommasino M. (ed.) Papillomaviruses in Human Cancer: the Role of E6 and E7 Oncoproteins. Heidelberg: Springer‐Verlag, 1997.
10. 10 Funk J.A., Waga S., Harry J.B., et al. Inhibition of CDK activity and PCNA‐dependent DNA replication by p21 is blocked by interaction with the HPV‐16, E7 oncoprotein. Genes Dev. 11: 2090 2100, 1997.
11. 11 Jones D.L., Alani R.M., Münger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1‐mediated inhibition of cdk2. Genes Dev. 11: 2101 2111, 1997.
12. 12 Zerfass‐Thome K., Zwerschke W., Mannhardt B., et al. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16, E7 oncoprotein. Oncogene 13: 2323 2330, 1996.
13. 13 Dürst M., Bosch F.X., Glitz D., et al. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV positive human cell lines. J. Virol. 65: 796 804, 1991.
14. 14 Rous P. & Beard J.W. Carcinomatous changes in virus‐induced papillomas of the skin of rabbits. Proc. Soc. Exp. Biol. Med. 32: 578 580, 1934.
15. 15 Rous P. & Friedewald W.F. The effect of chemical carcinogens on virus‐induced papillomas (Shope). J. Exp. Med. 79: 511 538, 1944.
16. 16 Lutz W. A propos de lepidermodysplasie verruciforme. Dermatologica 92: 30 43, 1946.
17. 17 Jablonska S. & Millewski B. Zur Kenntnis der Epidermodysplasia verruciformis Lewandowsky‐Lutz. Dermatologica 115: 1 22, 1957.
18. 18 Lewandowsky F. & Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch. Dermatol. Syph. (Berlin) 141: 193 203, 1922.
19. 19 Orth G., Jablonska S., Favre M., et al. Characterization of two new types of HPV from lesions of epidermodysplasia verruciformis. Proc. Natl. Acad. Sci. U.S.A. 75: 1537 1541, 1978.
20. 20 Orth G., Jablonska S., Jarzabek‐Chorzelska M., et al. Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39: 1074 1082, 1979.
21. 21 Von Knebel Doeberitz M., Rittmüller C., Glitz D., et al. Inhibition of tumorigenicity by cervical cancer cells in nude mice by HPV 18, E6–E7 antisense RNA. Int. J. Cancer 51: 831 834, 1992.
22. 22 Von Knebel Doeberitz M., Rittmüller C., Aengeneyndt F., et al. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6‐p53 and E7–pRB interactions. J. Virol. 68: 2811 2821, 1994.
23. 23 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 64 Human Papillomaviruses. Lyons: IARC, 1995.
24. 24 Schiffman M.H., Bauer H.M., Hoover R.N., et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85: 958 964, 1993.
25. 25 Shamanin V., Zur Hausen H., Lavergne D., et al. Human papillomavirus infections in non‐melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst. 88: 802 811, 1996.
26. 26 Berkhout R.J.M., Tieben L.M., Smits H.L., et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis‐associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol. 33: 690 695, 1995.
27. 27 De Villiers E.‐M., Lavergne D., McLaren K., Benton E.C. Prevailing papillomavirus types in non‐melanoma carcinomas of the skin in renal allograft recipients. Int. J. Cancer 73: 356 361, 1997.
28. 28 Purdie K., Pennington J., Proby C., et al. The promoter of a novel human papillomavirus HPV 77 associated with skin cancer displays UV‐responsiveness which is mediated through a consensus p53 binding sequence. E. M. B. O. J., in press.
29. 29 Chang F., Syrjänen S., Shen Q., et al. Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand. J. Gastroenterol. 27: 553 563, 1992.
30. 30 Lavergne D. & De Villiers E.‐M. Papillomavirus in oesophageal papillomas and carcinomas. Int. J. Cancer 80: 681 684, 1999.
31. 31 Zur Hausen H. Cell‐virus gene balance hypothesis of carcinogenesis. Behring Inst. Mitt. 61: 23 30, 1977.
32. 32 Zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 343: 955 957, 1994.
33. 33 Bosch F., Schwarz E., Boukamp P., et al. Suppression in vivo of human papillomavirus type 18, E6–E7 gene expression in nontumorigenic HeLa‐fibroblast hybrid cells. J. Virol. 64: 4743 4754, 1990.
34. 34 Dürst M., Glitz D., Schneider A., Zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization. Virology 189: 132 140, 1992.
35. 35 Rösl F., Lengert M., Albrecht J., et al. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP‐1) in cervical carcinoma cells and derived hybrids. J. Virol. 68: 2142 2150, 1994.
36. 36 Rösl F., Das B.C., Lengert M., et al. Antioxidant‐induced changes in AP‐1 composition result in a selective suppression of human papillomavirus transcription. J. Virol. 71: 362 370, 1997.
37. 37 Soto U., Das B.C., Lengert M., et al. Conversion of HPV 18 positive non‐tumorigenic HeLa‐fibroblast hybrids to invasive growth involves loss of TNF‐α mediated repression of viral transcription and modification of the AP‐1 transcription complex. Oncogene 18: 3187 3198, 1999.
38. 38 White A.E., Livanos E.M., Tlsty T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8: 666 677, 1994.
39. 39 Suzich J.A., Ghim S.J., Palmer‐Hill F.J., et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. U.S.A. 92: 11553 11557, 1995.
40. 40 Breitburd F., Kirnbauer R., Hubbert N.L., et al. Immunization with virus‐like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69: 3959 3963, 1995.
41. 41 Myers G., Baker C., Münger K., et al. (eds.). Human Papillomaviruses 1997, A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Los Alamos National Laboratory, 1997.